Experimental Oncology
  • Home
    • About edition
  • New issue
  • Archive
  • Author
  • Information for authors
  • Publications requirements
  • New website
  • Actual information
  • Book review
  • Brief report
  • Case reports
  • Clinical experience
  • Digest
  • Editorial
  • Exchange of experience
  • Experimental research
  • History of oncology
  • Information
  • International experience
  • Lectures
  • Materials of scientific conferences
  • Official information
  • Opinion
  • Original investigations
  • Review
  • Supplements
    Часопис online
    All news

    Ключевое слово :   safety

    RISC/BENEFIT PROFILE OF BEVACIZUMAB IN METASTATIC COLON CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
    RISC/BENEFIT PROFILE OF BEVACIZUMAB IN METASTATIC COLON CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Authors:La Verde N. №14 6 2012 8
    INTERNATIONAL EXPERIENCE FOR THE USE OF ALEMTUZUMAB IN THERAPY OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    INTERNATIONAL EXPERIENCE FOR THE USE OF ALEMTUZUMAB IN THERAPY OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    2019-04-04 7
    EFFICACY AND SAFETY OF HISTRELIN SUBDERMAL IMPLANT IN PATIENTS WITH ADVANCED PROSTATE CANCER
    EFFICACY AND SAFETY OF HISTRELIN SUBDERMAL IMPLANT IN PATIENTS WITH ADVANCED PROSTATE CANCER
    2019-04-04 5
    INTERNATIONAL EXPERIENCE FOR THE USE OF ALEMTUZUMAB IN THERAPY OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    INTERNATIONAL EXPERIENCE FOR THE USE OF ALEMTUZUMAB IN THERAPY OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    2019-04-04 4
    EFFICACY AND SAFETY OF HISTRELIN SUBDERMAL IMPLANT IN PATIENTS WITH ADVANCED PROSTATE CANCER
    EFFICACY AND SAFETY OF HISTRELIN SUBDERMAL IMPLANT IN PATIENTS WITH ADVANCED PROSTATE CANCER
    2019-04-04 2
    INTERNATIONAL EXPERIENCE FOR THE USE OF ALEMTUZUMAB IN THERAPY OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    INTERNATIONAL EXPERIENCE FOR THE USE OF ALEMTUZUMAB IN THERAPY OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    №12 3 2010 5
    EFFICACY AND SAFETY OF HISTRELIN SUBDERMAL IMPLANT IN PATIENTS WITH ADVANCED PROSTATE CANCER
    EFFICACY AND SAFETY OF HISTRELIN SUBDERMAL IMPLANT IN PATIENTS WITH ADVANCED PROSTATE CANCER
    №12 1 2010 1
    FARESTON® (ТOREMIFENE): MULTIPLE EFFECTS IN PRE-CANCER AND CANCER
    FARESTON® (ТOREMIFENE): MULTIPLE EFFECTS IN PRE-CANCER AND CANCER
    №11 1 2009 7
    Анонси та пресрелізи
    Всі новини
    Читаються за рейтингом

    INFLUENCE OF COVID19 AND VACCINATION AGAINST SARS-COV-2 ON...

    THE ROLE OF EUROPEAN TARGETED PROJECT CCI4EU IN...

    DIFFERENTIATED APPROACH TO THE TREATMENT OF PATIENTS WITH...

    IDENTIFICATION OF TARGET GENES FOR NOVEL METABOLIC STRATEGIES...

    EFFECT OF B. ANIMALIS AND B. SUBTILIS ІМВ...

    Publishing House “Akademperiodyka” Apteka online Компендиум — справочник лекарств №1 Chasopys online Oncology

    Publishing House “Akademperiodyka”
    Editorial office and publisher: 01004, Kyiv, 4 Tereschenkivska st.
    Tel.: +380 (44) 234-75-54

    Specialized medical online edition for doctors,
    pharmacists, students of medical and pharmaceutical universities
    pharmaceutical universities. Disclaimer

    Apteka online Компендиум Chasopys online Oncology